Flye M W, Mundinger G H, Fauci A S
J Thorac Cardiovasc Surg. 1979 Mar;77(3):331-7.
Over a 16 year period, 47 patients with Wegener's granulomatosis were treated at the National Institutes of Health. Age at the onset of disease ranged from 15 to 75 years with a mean of 42.2 years. The group was evenly divided between male and female subjects. With seven exceptions, all patients had the classic form of Wegener's granulomatosis, with upper airway and pulmonary disease and glomerulitis. The most consistently abnormal laboratory test was an elevated erythrocyte sedimentation rate. Most of the patients were treated with cyclophosphamide alone or in combination with prednisone. In 37 patients the disease now is well controlled or in complete remission from 1 to 9 years after the onset of symptoms. Of the 10 patients who died, only two were considered treatment failures. Forty-one of the 47 patients had chest x-ray changes at some point in their clinical course. Nineteen had bilateral involvement and 22 unilateral disease. Three of 11 patients with nodular disease had cavitation, and four of 21 with less discrete infiltrative disease demonstrated cavitation. Four patients had an associated pleural effusion and another four had pleural thickening. As part of the diagnostic procedure, 24 patients underwent an open lung biopsy. Two patients had a lobectomy for presumed neoplastic disease. In one patient the diagnosis of Wegener's granulomatosis was made by endobronchial biopsy. In the remaining patients the diagnosis was made by biopsy of another site. Endobronchial involvement is being seen with the increasing patient survival. Three patients had subglottic tracheal stenosis necessitating tracheal dilatations. One of the three also had multiple areas of bronchial stenosis responding to cyclophosphamide therapy. A fourth patient had progressive left main-stem bronchial stenosis which necessitated a sleeve resection. Five patients had pericarditis secondary to Wegener's granulomatosis.
在16年的时间里,美国国立卫生研究院对47例韦格纳肉芽肿患者进行了治疗。发病年龄在15岁至75岁之间,平均年龄为42.2岁。该组男女患者人数均等。除7例例外,所有患者均患有典型的韦格纳肉芽肿,伴有上呼吸道和肺部疾病以及肾小球肾炎。最常见的异常实验室检查是红细胞沉降率升高。大多数患者单独使用环磷酰胺或与泼尼松联合治疗。37例患者的疾病目前得到良好控制或在症状出现后1至9年完全缓解。在10例死亡患者中,只有2例被认为是治疗失败。47例患者中有41例在其临床病程的某个阶段出现胸部X线改变。19例为双侧受累,22例为单侧疾病。11例结节性疾病患者中有3例出现空洞,21例较散在浸润性疾病患者中有4例出现空洞。4例患者伴有胸腔积液,另外4例有胸膜增厚。作为诊断程序的一部分,24例患者接受了开胸肺活检。2例患者因疑似肿瘤性疾病接受了肺叶切除术。1例患者通过支气管内活检确诊为韦格纳肉芽肿。其余患者通过其他部位的活检确诊。随着患者生存率的提高,支气管内受累情况越来越常见。3例患者出现声门下气管狭窄,需要进行气管扩张。其中1例还出现多个支气管狭窄区域,对环磷酰胺治疗有反应。第4例患者出现进行性左主支气管狭窄,需要进行袖状切除术。5例患者因韦格纳肉芽肿继发心包炎。